What is the recommended diagnostic workup and management for colitis?

Diagnostic Workup and Management of Colitis

The diagnostic approach to colitis must first exclude infectious causes through stool testing before initiating immunosuppressive therapy, followed by endoscopic evaluation with biopsies to establish the specific type and severity of colitis, which then determines the treatment algorithm. 1, 2

Initial Diagnostic Workup

Immediate Assessment

• Exclude infectious causes first through comprehensive stool testing including bacterial culture, C. difficile toxin, and parasites before starting any immunosuppressive treatment 1
• Obtain complete blood count, CRP, ESR, serum electrolytes, albumin, and liver function tests 3
• Measure fecal inflammatory markers (calprotectin or lactoferrin) in patients with ≥4 bowel movements above baseline to stratify risk for endoscopic evaluation 1

Endoscopic Evaluation

• Perform colonoscopy with segmental biopsies to confirm diagnosis, assess disease extent, and evaluate severity 2
• For suspected immune checkpoint inhibitor (ICI) colitis, obtain endoscopic confirmation before initiating high-dose systemic glucocorticoids 1
• In acute severe presentations, flexible sigmoidoscopy without preparation is acceptable, with planned colonoscopy later to assess full disease extent 4

Imaging Considerations

• Reserve abdominal imaging (X-ray, CT, or ultrasound) for patients with dominant pain, fever, or bleeding to exclude complications like toxic megacolon (colon diameter ≥5.5 cm) 1, 2
• Do not routinely image patients with diarrhea alone 1
• Daily abdominal radiography is indicated if colonic dilatation detected at presentation 3

Management Based on Colitis Type and Severity

Ulcerative Colitis - Proctitis (Distal Disease)

• First-line: Mesalamine 1g suppository once daily is superior to topical steroids and more effective than oral mesalamine alone 2
• Combination therapy (topical mesalamine plus oral mesalamine or topical steroids) is more effective than monotherapy 3, 2
• For refractory proctitis failing oral corticosteroids combined with oral and rectal 5-ASA, consider IV steroid therapy or salvage therapies (cyclosporine, tacrolimus, or infliximab) 2

Ulcerative Colitis - Moderate to Severe Active Disease

• For biologic-naïve patients: Use infliximab or vedolizumab rather than adalimumab for induction of remission 5
• For patients with prior infliximab exposure (especially primary non-response): Use ustekinumab or tofacitinib rather than vedolizumab or adalimumab 5
• Oral prednisolone 40 mg daily for patients failing topical and oral mesalamine, tapered gradually over 8 weeks 3

Acute Severe Ulcerative Colitis (Truelove and Witts Criteria)

Criteria: ≥6 bloody stools/day PLUS one of: tachycardia >90/min, temperature >37.8°C, hemoglobin <10.5 g/dL, or ESR >30 mm/h (or CRP >30 mg/L) 2

Management protocol:

• Joint medical-surgical management from admission with daily colorectal surgery consultation 3
• IV hydrocortisone with monitoring of vital signs four times daily 3
• IV fluid and electrolyte replacement, blood transfusion to maintain hemoglobin >10 g/dL 3
• Subcutaneous heparin for thromboembolism prophylaxis 3
• Monitor FBC, CRP, electrolytes, albumin every 24-48 hours 3
• For steroid-refractory disease: Infliximab or vedolizumab are reasonable second-line options 1
• Inform patients of 25-30% colectomy risk 3

Toxic Megacolon

• Empirical oral vancomycin until C. difficile excluded, in addition to IV hydrocortisone 2
• Immediate colorectal surgery consultation on day of admission 2
• Early colectomy without rapid improvement given limited window for medical therapy 2

Immune Checkpoint Inhibitor Colitis

• High-dose systemic glucocorticoids (0.5-2 mg/kg prednisone equivalent daily) with 4-6 week taper 1
• For glucocorticoid-refractory disease: Infliximab or vedolizumab 1
• Budesonide ineffective for prophylaxis but may treat ICI-associated microscopic colitis 1
• Recognize rapid progression can occur within days, particularly with ipilimumab, requiring prompt diagnosis and treatment 1

Maintenance Therapy

Ulcerative Colitis in Remission

• Lifelong maintenance therapy recommended with aminosalicylates, azathioprine, or mercaptopurine to reduce relapse risk and potentially colorectal cancer risk 3
• For steroid-dependent disease: thiopurines, anti-TNF (preferably combined with thiopurines for infliximab), vedolizumab, or methotrexate 2

Critical Pitfalls to Avoid

• Never delay infectious workup before immunosuppression, as this increases mortality risk 1
• Do not use budesonide for ICI colitis prophylaxis - it is ineffective 1
• Avoid anti-diarrheal agents in severe colitis as they increase toxic megacolon risk 2
• Do not miss proximal constipation in distal colitis - obtain abdominal X-ray and treat with laxatives if fecal loading present, as this affects drug delivery 2
• Reassess diagnosis if refractory to treatment - consider poor adherence, inadequate drug delivery, unrecognized infection, or alternative diagnoses (IBS, Crohn's disease, malignancy) 2